Unique ID issued by UMIN | UMIN000042925 |
---|---|
Receipt number | R000048949 |
Scientific Title | Study of ingestion of fatty acid and amino acid for muscle damage: a randomized, double-blind, placebo-controlled, parallel-group trial |
Date of disclosure of the study information | 2021/01/15 |
Last modified on | 2021/07/07 11:42:59 |
Study of fatty acid and amino acid for muscle damage
Study of fatty acid and amino acid for muscle damage
Study of ingestion of fatty acid and amino acid for muscle damage: a randomized, double-blind, placebo-controlled, parallel-group trial
Study of fatty acid and amino acid for muscle damage
Japan |
muscle damage
Not applicable |
Others
NO
The purpose of this study is to investigate the influence of fatty acid and amino acid for muscle damage following eccentric contractions.
Efficacy
Confirmatory
Not applicable
Before and after eccentric contraction (ECCs) with elbow flexors,
1)Range of motion
2)Maximal isometric contraction torque
3)Muscle soreness measured as a visual analog scale
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Educational,Counseling,Training
Food |
Ingestion of the placebo fatty acid oil (2.4 g/day) for 8 weeks before ECCs and for 6 days after ECCs.
Ingestion of the placebo starch (9.6 g/day) for 4 days before ECCs.
Ingestion of the placebo fatty acid oil (2.4 g/day) for 8 weeks before ECCs and for 6 days after ECCs.
Ingestion of the amino acid (9.6 g/day) for 4 days before ECCs.
Ingestion of the fatty acid oil (2.4 g/day) for 8 weeks before ECCs and for 6 days after ECCs.
Ingestion of the amino acid (9.6 g/day) for 4 days before ECCs.
18 | years-old | <= |
Not applicable |
Male
Healthy male subjects
Subjects with
/resistance training more than five times a week for a year /no resistance training or exercise during over a year /serious liver, kidney, heart, respiratory, endocrine or metabolic diseases/ scheduled for surgery during this study/ administration of regular medication/ regular administration of supplements which affect this study / food allergies/ participation of other clinical trial during this study/ restriction of exercise/ any reason in the opinion of the lead principal investigator not to take part in this study
30
1st name | Eisuke |
Middle name | |
Last name | Ochi |
Hosei University
Faculty of Bioscience and Applied Chemistry
1848584
3-7-2 Kajino, Koganei, Tokyo
042-387-6337
ochi@hosei.ac.jp
1st name | Eisuke |
Middle name | |
Last name | Ochi |
Hosei University
Faculty of Bioscience and Applied Chemistry
1848584
3-7-2 Kajino, Koganei, Tokyo
042-387-6337
ochi@hosei.ac.jp
Hosei University
Faculty of Bioscience and Applied Chemistry
Nippon Suisan Kaisha Ltd.
Profit organization
Japan
Teikyo Heisei University
Research Ethics Committee of Teikyo Heisei University
2-51-4, Higashiikebukuro, Toshima-ku, Tokyo, Japan
03-5843-3152
rec@thu.ac.jp
NO
2021 | Year | 01 | Month | 15 | Day |
Unpublished
Completed
2020 | Year | 12 | Month | 20 | Day |
2020 | Year | 09 | Month | 07 | Day |
2021 | Year | 01 | Month | 15 | Day |
2021 | Year | 03 | Month | 31 | Day |
2021 | Year | 01 | Month | 06 | Day |
2021 | Year | 07 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048949
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |